A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP

Abroad (travel likely)RecruitingPHASE3

Conditions

Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hunan University Of Medicine General Hospital, Huaihua, Hunan, China
Contact: Study coordinator (jianliang Zhou, master) · 82125817@qq.com · 0745-2383818

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex

Hospital-acquired Bacterial Pneumonia · Ventilator-associated Bacterial Pneumonia

IsraelRecruitingPHASE2

Ashdod, Israel · Be’er Ya‘aqov, Israel

Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections

Hospital-acquired Bacterial Pneumonia (HABP) · Ventilator-associated Bacterial Pneumonia (VABP) · Complicated Intra-abdominal Infection (cIAI)

Abroad (travel likely)RecruitingPHASE3

Shanghai, China

Optimising TREATment for Severe Gram-Negative Bacterial Infections

Bloodstream Infection · Ventilator Associated Bacterial Pneumonia · Hospital Acquired Bacterial Pneumonia

Abroad (travel likely)RecruitingPHASE4

Brisbane, Australia · Brisbane, Australia

A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia

Hospital-acquired Bacterial Pneumonia (HABP) · Ventilator-associated Bacterial Pneumonia (VABP)

Abroad (travel likely)RecruitingPHASE2

Beijing, China